GITNUXREPORT 2026

Drug Usage Statistics

Illicit drug use remains widespread and dangerous, causing immense societal and economic harm worldwide.

Rajesh Patel

Rajesh Patel

Team Lead & Senior Researcher with over 15 years of experience in market research and data analytics.

First published: Feb 13, 2026

Our Commitment to Accuracy

Rigorous fact-checking · Reputable sources · Regular updatesLearn more

Key Statistics

Statistic 1

In U.S., males aged 18-25 have 2.5 times higher past-year drug use rate than females per NSDUH 2022.

Statistic 2

Non-Hispanic Whites had 25.1% past-year illicit drug use vs 22.4% for Blacks in 2022 NSDUH.

Statistic 3

Urban residents showed 26.3% past-year drug use vs 21.8% rural in 2022 U.S. data.

Statistic 4

College graduates had lower 15.2% drug use rate vs 28.4% high school only in 2022.

Statistic 5

LGBTQ+ youth report 40% past-year illicit drug use vs 15% heterosexual peers per CDC 2023.

Statistic 6

American Indian/Alaska Native adults have 2x opioid misuse rate vs national average per SAMHSA.

Statistic 7

Employed full-time adults had 22.1% past-month alcohol use disorder vs 14.5% unemployed per NSDUH.

Statistic 8

Hispanics had 20.8% marijuana past-year use vs 17.1% non-Hispanics in 2022.

Statistic 9

Males account for 70% of methamphetamine users aged 12+ per NSDUH 2022.

Statistic 10

Adults 26+ in U.S. had highest prescription misuse at 4.1% vs youth per 2022 data.

Statistic 11

Low-income households (<$20k) showed 30.2% drug use vs 18.5% high-income per NSDUH.

Statistic 12

Females aged 12-17 had higher inhalant use at 4.2% vs 3.6% males in MTFS 2023.

Statistic 13

Asian Americans lowest drug use at 12.4% past-year vs other groups per CDC.

Statistic 14

Veterans have 11% past-year opioid misuse vs 4.9% civilians per VA 2022.

Statistic 15

Rural youth 12-17 have 1.5x higher misuse of pain relievers per SAMHSA.

Statistic 16

College-aged males 19-22 use marijuana 2x more than females per MTFS.

Statistic 17

Black youth highest cocaine use at 1.8% past-year vs Whites 0.9% per NSDUH.

Statistic 18

Unmarried adults have 28% drug use rate vs 19% married per 2022 data.

Statistic 19

Drug use costs U.S. economy $1.02 trillion annually including lost productivity per NIH 2023.

Statistic 20

Opioid crisis cost U.S. $1.02 trillion in 2020 per CDC economic burden study.

Statistic 21

Workplace drug use leads to 70% higher absenteeism costing $84 billion yearly per NSF.

Statistic 22

Methamphetamine societal costs estimated at $23.4 billion annually in U.S. per RAND.

Statistic 23

Prescription opioid misuse costs healthcare $78.5 billion per year per IOM report.

Statistic 24

Global illicit drug trade valued at $650 billion in 2022 per UNODC.

Statistic 25

Alcohol-related healthcare costs $249 billion annually in U.S. per CDC.

Statistic 26

Crime costs from drug use total $193 billion yearly in U.S. per NIH.

Statistic 27

Tobacco economic burden $300 billion/year in U.S. healthcare and productivity per CDC.

Statistic 28

Heroin production and trafficking generate $50 billion for cartels annually per DEA.

Statistic 29

Lost lifetime earnings from opioid deaths $504 billion for 2001-2021 cohort per CDC.

Statistic 30

Cocaine-related criminal justice costs $38 billion/year in U.S. per ONDCP.

Statistic 31

Emergency department visits for drugs cost $34 billion annually per HCUP.

Statistic 32

Marijuana legalization saved states $3.6 billion in enforcement costs 2017-2022 per ACLU.

Statistic 33

Fentanyl trafficking costs U.S. customs $2.5 billion in interdiction yearly per CBP.

Statistic 34

Treatment for SUD costs $42 billion/year but saves $7 for each $1 spent per NIH.

Statistic 35

Chronic heroin use led to 109,000 overdose deaths globally in 2021 UNODC.

Statistic 36

Opioid overdose deaths in U.S. reached 81,806 in 2022 per CDC NVSS.

Statistic 37

Fentanyl was involved in 68% of all U.S. drug overdose deaths in 2022 CDC data.

Statistic 38

Marijuana use associated with 22% increased risk of schizophrenia per 2023 meta-analysis in Lancet.

Statistic 39

Cocaine use causes 14,000 cardiovascular deaths annually in U.S. per NIH estimates.

Statistic 40

Methamphetamine use linked to 1.5 times higher stroke risk in users under 45 per JAMA 2022.

Statistic 41

Heroin injection leads to HIV infection in 10% of users within 5 years per CDC.

Statistic 42

Alcohol misuse contributes to 140,000 deaths yearly in U.S. including liver cirrhosis per CDC.

Statistic 43

Tobacco smoking causes 480,000 deaths annually in U.S. per CDC 2023.

Statistic 44

Benzodiazepine overdose deaths rose 4-fold from 2002-2019 to 12,000 per CDC.

Statistic 45

Cannabis hyperemesis syndrome hospitalizations increased 4.5 times from 2017-2021 per NEJM.

Statistic 46

Opioid use disorder increases suicide risk 10-fold per 2022 JAMA Psychiatry study.

Statistic 47

Meth use associated with 3.7 times higher Parkinson's risk per Neurology 2023.

Statistic 48

Cocaine cardiomyopathy affects 25% of chronic users per Circulation 2021.

Statistic 49

Heroin withdrawal symptoms peak at 48-72 hours in 90% of users per NIDA.

Statistic 50

MDMA use impairs serotonin function for up to 2 years in 70% of heavy users per NIH.

Statistic 51

Kratom-related seizures reported in 1,800 cases to FDA from 2011-2022.

Statistic 52

Psilocybin accidental ingestion leads to 7,000 ER visits yearly in U.S. per CDC.

Statistic 53

Stimulant use during pregnancy increases preterm birth risk by 40% per JAMA 2022.

Statistic 54

In 2022, an estimated 70.2 million people aged 12 or older (24.9% of the population) had used illicit drugs in the past year according to the NSDUH.

Statistic 55

Lifetime prevalence of marijuana use among U.S. adults aged 18+ reached 52.5% in 2021 per CDC data.

Statistic 56

In 2023, 18.7% of U.S. adolescents aged 12-17 reported past-year use of any illicit drug excluding marijuana.

Statistic 57

Global past-year cannabis use prevalence was 4.0% (219 million users) in 2022 according to UNODC World Drug Report.

Statistic 58

Opioid use disorder affected 6.1 million people aged 12+ in the U.S. in 2021 per SAMHSA NSDUH.

Statistic 59

Past-month cocaine use among U.S. adults was 2.0% (5.2 million people) in 2022 NSDUH data.

Statistic 60

Hallucinogen past-year use prevalence was 3.0% among young adults aged 18-25 in 2022.

Statistic 61

Inhalant use in the past year among 8th graders dropped to 3.9% in 2023 MTFS.

Statistic 62

Methamphetamine past-year use was 1.7% among U.S. adults 18+ in 2022 NSDUH.

Statistic 63

Global amphetamine-type stimulant use reached 34 million past-year users in 2022 per UNODC.

Statistic 64

Past-month prescription pain reliever misuse was 3.4% among U.S. youth 12-17 in 2022.

Statistic 65

Ecstasy/MDMA past-year use prevalence was 2.7% for young adults in 2023 MTFS.

Statistic 66

Heroin past-year use affected 0.9 million U.S. people 12+ in 2021 NSDUH.

Statistic 67

Global cocaine use prevalence was 1.0% (22 million users) in 2022 UNODC report.

Statistic 68

Past-year tranquilizer misuse was 2.1% among U.S. adults in 2022.

Statistic 69

LSD past-year use was 1.1% among college students in 2023 MTFS.

Statistic 70

In 2022, 48.7 million U.S. people 12+ used marijuana in past year (17.3%).

Statistic 71

Synthetic cannabinoid past-year use was 1.2% among high school seniors in 2023.

Statistic 72

Fentanyl past-year use estimated at 3.5 million among U.S. adults in 2022 CDC data.

Statistic 73

Global opioid use disorder prevalence was 60 million in 2022 per WHO.

Statistic 74

2.3 million U.S. adults received SUD treatment in 2022 per NSDUH.

Statistic 75

Only 10.3% of people with heroin use disorder received treatment in past year per SAMHSA.

Statistic 76

Medication-assisted treatment (MAT) with buprenorphine reached 875,000 users in 2022 CDC.

Statistic 77

SUD treatment admissions dropped 20% during COVID to 1.4 million in 2021 per TEDS.

Statistic 78

90-day residential treatment success rate 50-60% for opioids per NIDA studies.

Statistic 79

Methadone programs serve 405,000 patients daily in U.S. per SAMHSA 2023.

Statistic 80

Relapse rate within 1 year post-treatment is 40-60% for cocaine SUD per NIH.

Statistic 81

Contingency management boosts abstinence 50% in stimulant treatment per APA.

Statistic 82

21.3 million needed SUD treatment but only 4.3 million received it in 2022 NSDUH.

Statistic 83

Naloxone distribution prevented 26,000 overdose deaths 1996-2021 per CDC.

Statistic 84

Buprenorphine prescriptions increased 128% from 2013-2022 to 8 million per IQVIA.

Statistic 85

12-step programs like AA achieve 20-30% abstinence at 1 year per meta-analysis.

Statistic 86

Telehealth SUD treatment visits surged 60% in 2022 per CMS data.

Statistic 87

Youth SUD treatment completion rate 65% for outpatient vs 50% residential per SAMHSA.

Statistic 88

Polysubstance treatment success 35% lower than single substance per NIDA.

Sources
Trusted by 500+ publications
Harvard Business ReviewThe GuardianFortune+497
Stark statistics reveal a drug use crisis touching every corner of society, and we must confront its scale and devastating human cost directly.

Key Takeaways

  • In 2022, an estimated 70.2 million people aged 12 or older (24.9% of the population) had used illicit drugs in the past year according to the NSDUH.
  • Lifetime prevalence of marijuana use among U.S. adults aged 18+ reached 52.5% in 2021 per CDC data.
  • In 2023, 18.7% of U.S. adolescents aged 12-17 reported past-year use of any illicit drug excluding marijuana.
  • Chronic heroin use led to 109,000 overdose deaths globally in 2021 UNODC.
  • Opioid overdose deaths in U.S. reached 81,806 in 2022 per CDC NVSS.
  • Fentanyl was involved in 68% of all U.S. drug overdose deaths in 2022 CDC data.
  • In U.S., males aged 18-25 have 2.5 times higher past-year drug use rate than females per NSDUH 2022.
  • Non-Hispanic Whites had 25.1% past-year illicit drug use vs 22.4% for Blacks in 2022 NSDUH.
  • Urban residents showed 26.3% past-year drug use vs 21.8% rural in 2022 U.S. data.
  • Drug use costs U.S. economy $1.02 trillion annually including lost productivity per NIH 2023.
  • Opioid crisis cost U.S. $1.02 trillion in 2020 per CDC economic burden study.
  • Workplace drug use leads to 70% higher absenteeism costing $84 billion yearly per NSF.
  • 2.3 million U.S. adults received SUD treatment in 2022 per NSDUH.
  • Only 10.3% of people with heroin use disorder received treatment in past year per SAMHSA.
  • Medication-assisted treatment (MAT) with buprenorphine reached 875,000 users in 2022 CDC.

Illicit drug use remains widespread and dangerous, causing immense societal and economic harm worldwide.

Demographics

  • In U.S., males aged 18-25 have 2.5 times higher past-year drug use rate than females per NSDUH 2022.
  • Non-Hispanic Whites had 25.1% past-year illicit drug use vs 22.4% for Blacks in 2022 NSDUH.
  • Urban residents showed 26.3% past-year drug use vs 21.8% rural in 2022 U.S. data.
  • College graduates had lower 15.2% drug use rate vs 28.4% high school only in 2022.
  • LGBTQ+ youth report 40% past-year illicit drug use vs 15% heterosexual peers per CDC 2023.
  • American Indian/Alaska Native adults have 2x opioid misuse rate vs national average per SAMHSA.
  • Employed full-time adults had 22.1% past-month alcohol use disorder vs 14.5% unemployed per NSDUH.
  • Hispanics had 20.8% marijuana past-year use vs 17.1% non-Hispanics in 2022.
  • Males account for 70% of methamphetamine users aged 12+ per NSDUH 2022.
  • Adults 26+ in U.S. had highest prescription misuse at 4.1% vs youth per 2022 data.
  • Low-income households (<$20k) showed 30.2% drug use vs 18.5% high-income per NSDUH.
  • Females aged 12-17 had higher inhalant use at 4.2% vs 3.6% males in MTFS 2023.
  • Asian Americans lowest drug use at 12.4% past-year vs other groups per CDC.
  • Veterans have 11% past-year opioid misuse vs 4.9% civilians per VA 2022.
  • Rural youth 12-17 have 1.5x higher misuse of pain relievers per SAMHSA.
  • College-aged males 19-22 use marijuana 2x more than females per MTFS.
  • Black youth highest cocaine use at 1.8% past-year vs Whites 0.9% per NSDUH.
  • Unmarried adults have 28% drug use rate vs 19% married per 2022 data.

Demographics Interpretation

America's drug use landscape paints a picture where geography, gender, and GPA are surprisingly predictive, but it’s the shadows cast by identity, trauma, and inequality that reveal the most about who is really hurting.

Economic Costs

  • Drug use costs U.S. economy $1.02 trillion annually including lost productivity per NIH 2023.
  • Opioid crisis cost U.S. $1.02 trillion in 2020 per CDC economic burden study.
  • Workplace drug use leads to 70% higher absenteeism costing $84 billion yearly per NSF.
  • Methamphetamine societal costs estimated at $23.4 billion annually in U.S. per RAND.
  • Prescription opioid misuse costs healthcare $78.5 billion per year per IOM report.
  • Global illicit drug trade valued at $650 billion in 2022 per UNODC.
  • Alcohol-related healthcare costs $249 billion annually in U.S. per CDC.
  • Crime costs from drug use total $193 billion yearly in U.S. per NIH.
  • Tobacco economic burden $300 billion/year in U.S. healthcare and productivity per CDC.
  • Heroin production and trafficking generate $50 billion for cartels annually per DEA.
  • Lost lifetime earnings from opioid deaths $504 billion for 2001-2021 cohort per CDC.
  • Cocaine-related criminal justice costs $38 billion/year in U.S. per ONDCP.
  • Emergency department visits for drugs cost $34 billion annually per HCUP.
  • Marijuana legalization saved states $3.6 billion in enforcement costs 2017-2022 per ACLU.
  • Fentanyl trafficking costs U.S. customs $2.5 billion in interdiction yearly per CBP.
  • Treatment for SUD costs $42 billion/year but saves $7 for each $1 spent per NIH.

Economic Costs Interpretation

America’s drug problem is an economic hemorrhage disguised as a moral debate, bleeding out over a trillion dollars a year while we argue over tourniquets.

Health Effects

  • Chronic heroin use led to 109,000 overdose deaths globally in 2021 UNODC.
  • Opioid overdose deaths in U.S. reached 81,806 in 2022 per CDC NVSS.
  • Fentanyl was involved in 68% of all U.S. drug overdose deaths in 2022 CDC data.
  • Marijuana use associated with 22% increased risk of schizophrenia per 2023 meta-analysis in Lancet.
  • Cocaine use causes 14,000 cardiovascular deaths annually in U.S. per NIH estimates.
  • Methamphetamine use linked to 1.5 times higher stroke risk in users under 45 per JAMA 2022.
  • Heroin injection leads to HIV infection in 10% of users within 5 years per CDC.
  • Alcohol misuse contributes to 140,000 deaths yearly in U.S. including liver cirrhosis per CDC.
  • Tobacco smoking causes 480,000 deaths annually in U.S. per CDC 2023.
  • Benzodiazepine overdose deaths rose 4-fold from 2002-2019 to 12,000 per CDC.
  • Cannabis hyperemesis syndrome hospitalizations increased 4.5 times from 2017-2021 per NEJM.
  • Opioid use disorder increases suicide risk 10-fold per 2022 JAMA Psychiatry study.
  • Meth use associated with 3.7 times higher Parkinson's risk per Neurology 2023.
  • Cocaine cardiomyopathy affects 25% of chronic users per Circulation 2021.
  • Heroin withdrawal symptoms peak at 48-72 hours in 90% of users per NIDA.
  • MDMA use impairs serotonin function for up to 2 years in 70% of heavy users per NIH.
  • Kratom-related seizures reported in 1,800 cases to FDA from 2011-2022.
  • Psilocybin accidental ingestion leads to 7,000 ER visits yearly in U.S. per CDC.
  • Stimulant use during pregnancy increases preterm birth risk by 40% per JAMA 2022.

Health Effects Interpretation

The grim arithmetic of addiction proves that while some substances might seem to offer an escape, they are far more likely to provide a final, tragic tally.

Prevalence

  • In 2022, an estimated 70.2 million people aged 12 or older (24.9% of the population) had used illicit drugs in the past year according to the NSDUH.
  • Lifetime prevalence of marijuana use among U.S. adults aged 18+ reached 52.5% in 2021 per CDC data.
  • In 2023, 18.7% of U.S. adolescents aged 12-17 reported past-year use of any illicit drug excluding marijuana.
  • Global past-year cannabis use prevalence was 4.0% (219 million users) in 2022 according to UNODC World Drug Report.
  • Opioid use disorder affected 6.1 million people aged 12+ in the U.S. in 2021 per SAMHSA NSDUH.
  • Past-month cocaine use among U.S. adults was 2.0% (5.2 million people) in 2022 NSDUH data.
  • Hallucinogen past-year use prevalence was 3.0% among young adults aged 18-25 in 2022.
  • Inhalant use in the past year among 8th graders dropped to 3.9% in 2023 MTFS.
  • Methamphetamine past-year use was 1.7% among U.S. adults 18+ in 2022 NSDUH.
  • Global amphetamine-type stimulant use reached 34 million past-year users in 2022 per UNODC.
  • Past-month prescription pain reliever misuse was 3.4% among U.S. youth 12-17 in 2022.
  • Ecstasy/MDMA past-year use prevalence was 2.7% for young adults in 2023 MTFS.
  • Heroin past-year use affected 0.9 million U.S. people 12+ in 2021 NSDUH.
  • Global cocaine use prevalence was 1.0% (22 million users) in 2022 UNODC report.
  • Past-year tranquilizer misuse was 2.1% among U.S. adults in 2022.
  • LSD past-year use was 1.1% among college students in 2023 MTFS.
  • In 2022, 48.7 million U.S. people 12+ used marijuana in past year (17.3%).
  • Synthetic cannabinoid past-year use was 1.2% among high school seniors in 2023.
  • Fentanyl past-year use estimated at 3.5 million among U.S. adults in 2022 CDC data.
  • Global opioid use disorder prevalence was 60 million in 2022 per WHO.

Prevalence Interpretation

This data reveals that drug use isn't a fringe issue but a sprawling, multi-faceted reality, where experimental college LSD trips and deadly opioid epidemics uncomfortably share the same national spreadsheet.

Treatment

  • 2.3 million U.S. adults received SUD treatment in 2022 per NSDUH.
  • Only 10.3% of people with heroin use disorder received treatment in past year per SAMHSA.
  • Medication-assisted treatment (MAT) with buprenorphine reached 875,000 users in 2022 CDC.
  • SUD treatment admissions dropped 20% during COVID to 1.4 million in 2021 per TEDS.
  • 90-day residential treatment success rate 50-60% for opioids per NIDA studies.
  • Methadone programs serve 405,000 patients daily in U.S. per SAMHSA 2023.
  • Relapse rate within 1 year post-treatment is 40-60% for cocaine SUD per NIH.
  • Contingency management boosts abstinence 50% in stimulant treatment per APA.
  • 21.3 million needed SUD treatment but only 4.3 million received it in 2022 NSDUH.
  • Naloxone distribution prevented 26,000 overdose deaths 1996-2021 per CDC.
  • Buprenorphine prescriptions increased 128% from 2013-2022 to 8 million per IQVIA.
  • 12-step programs like AA achieve 20-30% abstinence at 1 year per meta-analysis.
  • Telehealth SUD treatment visits surged 60% in 2022 per CMS data.
  • Youth SUD treatment completion rate 65% for outpatient vs 50% residential per SAMHSA.
  • Polysubstance treatment success 35% lower than single substance per NIDA.

Treatment Interpretation

The story of America's fight against addiction is one of glaring contradictions: we are getting much better at prescribing life-saving medicine for substance use disorders, yet we still fail to treat the overwhelming majority of people who need it.